The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026

• Citation: S.I. 2026/614
• Sections: 2

Section 1 Citation, commencement and extent

(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2026 and come into force on 1st July 2026.

(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.

Section 2 Amendments to the Branded Health Service Medicines (Costs) Regulations 2018

(1) Regulation 3 (payment scheme) of the Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.

(2) In paragraph (1), for the table substitute the following table—

Table

(3) In paragraph (1AB)—

(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026” ; and

(b) for “31.3% and not 23.4%”, substitute “8.7% and not 16.5%” .

(4) In paragraph (1AC)—

(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026” ;

(b) in sub-paragraph (a), for “1st January 2025 and ending at the end of 30 June 2025”, substitute “1st January 2026 and ending at the end of 30 June 2026” ; and

(c) in sub-paragraph (b), for “15.5%”, substitute “24.3%” .